Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice
Authors:
- 28 February 2019
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 33 (9) , e13514
Abstract
These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of viral hepatitis in the pre‐ and post‐transplant period. The current guidelines reflect the declining need for hepatitis B immunoglobulin following liver transplant, now replaced with nucleos(t)ide analogues that effectively suppress viral replication for the long term with minimal risk for drug resistance. It describes the limitations of pegylated interferon alpha in the treatment for chronic hepatitis D. The guidelines feature the paradigm shift in the treatment arena of chronic hepatitis C, now consisting of highly effective direct‐acting antiviral (DAA) medications that effect a cure almost universally. Its safety profile and easy tolerance have permitted its use in patients with decompensated cirrhosis and/or end‐stage renal disease. The high potency of the DAA's has fueled the rapidly expanding utilization of hepatitis C‐exposed grafts in non‐hepatitis C‐infected liver, heart, or kidney recipients within structured protocols, followed by viral eradication with DAA therapy in the peri‐ or post‐transplant period. Chronic hepatitis E has become more recognized in the solid‐organ transplant recipients, and the therapeutic approach has been streamlined to start with reduction of immunosuppression, and if indicated afterward, ribavirin monotherapy.Keywords
This publication has 230 references indexed in Scilit:
- Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern CaliforniaJournal of Gastroenterology and Hepatology, 2013
- Risk of advanced fibrosis with grafts from hepatitis C antibody–positive donors: A multicenter cohort studyLiver Transplantation, 2012
- Standardization of Hepatitis E Virus (HEV) Nucleic Acid Amplification Technique-Based Assays: an Initial Study To Evaluate a Panel of HEV Strains and Investigate Laboratory PerformanceJournal of Clinical Microbiology, 2011
- Risk of Window Period Hepatitis-C Infection in High Infectious Risk Donors: Systematic Review and Meta-AnalysisAmerican Journal of Transplantation, 2011
- Prevalence, Correlates, and Viral Dynamics of Hepatitis Delta among Injection Drug UsersThe Journal of Infectious Diseases, 2010
- HBV and HIV Coinfection and Liver TransplantAmerican Journal of Transplantation, 2010
- Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United StatesGastroenterology, 2009
- Epidemiology of Hepatitis E Virus in the United States: Results from the Third National Health and Nutrition Examination Survey, 1988–1994The Journal of Infectious Diseases, 2009
- Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive ImmunoprophylaxisHepatology, 2003
- Hepatitis delta virus as a global health problemVaccine, 1990